TerrAscend Common Stock Net 2021-2025 | TSNDF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

TerrAscend common stock net from 2021 to 2025. Common stock net can be defined as the value of common equity ownership.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

TerrAscend common stock net from 2021 to 2025. Common stock net can be defined as the value of common equity ownership.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$218.9B
Boston Scientific (BSX)	$159.4B
Stryker (SYK)	$153B
EssilorLuxottica (ESLOY)	$136.1B
Medtronic (MDT)	$118B
Lonza Group Ag (LZAGY)	$50.9B
Haleon (HLN)	$43.8B
ResMed (RMD)	$40.1B
GE HealthCare Technologies (GEHC)	$35.4B
Agilent Technologies (A)	$33.9B
Terumo (TRUMY)	$25.3B
Koninklijke Philips (PHG)	$24.9B
Insulet (PODD)	$20.2B
Zimmer Biomet Holdings (ZBH)	$19.3B
Baxter (BAX)	$14.7B
Smith & Nephew SNATS (SNN)	$13.9B
Sunny Optical Technology (SNPTF)	$10.4B
Demant (WILYY)	$8.6B
Bio-Rad Laboratories (BIO)	$7B
Lantheus Holdings (LNTH)	$5.1B
Perrigo (PRGO)	$3.9B
Prestige Consumer Healthcare (PBH)	$3.8B
Haemonetics (HAE)	$3.6B
Envista Holdings (NVST)	$3.5B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
ICU Medical (ICUI)	$3.2B
LeMaitre Vascular (LMAT)	$1.9B
QuidelOrtho (QDEL)	$1.8B
AtriCure (ATRC)	$1.5B
Acuren (TIC)	$1.4B